메뉴 건너뛰기




Volumn 36, Issue 1, 2011, Pages 41-52

Less frequent requests for 111In-pentreotide and its brothers of endocrinological interest

Author keywords

Paraneoplastic syndromes; Receptors, somatostatin; Surgical procedures, operative

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GA 68; CORTICOSTEROID; DOTATATE LU 177; DOTATOC Y 90; PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; TRACER; UNCLASSIFIED DRUG;

EID: 79959919176     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (29)

References (71)
  • 1
    • 0015914428 scopus 로고
    • Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
    • Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.
    • (1973) Science , vol.179 , pp. 77-79
    • Brazeau, P.1    Vale, W.2    Burgus, R.3    Ling, N.4    Butcher, M.5    Rivier, J.6
  • 2
    • 0032780823 scopus 로고    scopus 로고
    • Somatostatin and its receptor family
    • DOI 10.1006/frne.1999.0183
    • Patel YC. Somatostatin and its receptor family. Frontiers in Neuroendocrinology 1999;20:157-98. (Pubitemid 29362641)
    • (1999) Frontiers in Neuroendocrinology , vol.20 , Issue.3 , pp. 157-198
    • Patel, Y.C.1
  • 3
    • 0023574423 scopus 로고
    • Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
    • Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987;47:5758-64. (Pubitemid 18046777)
    • (1987) Cancer Research , vol.47 , Issue.21 , pp. 5758-5764
    • Reubi, J.C.1    Lang, W.2    Maurer, R.3    Koper, J.W.4    Lamberts, S.W.J.5
  • 4
    • 0024117485 scopus 로고
    • The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
    • Lamberts SW. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocrine Reviews 1988;9:417-36.
    • (1988) Endocrine Reviews , vol.9 , pp. 417-436
    • Lamberts, S.W.1
  • 5
    • 0042854927 scopus 로고    scopus 로고
    • Peptide receptors as molecular targets for cancer diagnosis and therapy
    • DOI 10.1210/er.2002-0007
    • Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003;24:389-427. (Pubitemid 37056239)
    • (2003) Endocrine Reviews , vol.24 , Issue.4 , pp. 389-427
    • Reubi, J.C.1
  • 7
    • 4444323262 scopus 로고    scopus 로고
    • Neuroendocrine tumors-somatostatin receptor expression and somatostatin analog treatment
    • Janson ET, Oberg K. Neuroendocrine tumors-somatostatin receptor expression and somatostatin analog treatment. Cancer Chemother Biol Response Modif 2003;21:535-46.
    • (2003) Cancer Chemother Biol Response Modif , vol.21 , pp. 535-546
    • Janson, E.T.1    Oberg, K.2
  • 8
    • 6044266281 scopus 로고    scopus 로고
    • Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment
    • Reubi JC. Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 2004;80:51-6.
    • (2004) Neuroendocrinology , vol.80 , pp. 51-56
    • Reubi, J.C.1
  • 9
    • 0034924612 scopus 로고    scopus 로고
    • Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
    • DOI 10.1007/s002590100541
    • Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836-46. (Pubitemid 32662546)
    • (2001) European Journal of Nuclear Medicine , vol.28 , Issue.7 , pp. 836-846
    • Reubi, J.C.1    Waser, B.2    Schaer, J.-C.3    Laissue, J.A.4
  • 10
    • 0031201409 scopus 로고    scopus 로고
    • Somatostatin receptor subtype expression in human tissues: A prediction for diagnosis and treatment of cancer
    • Virgolini I, Pangeri T, Bischof C, Smith-Jones P, PeckRadosavljevic M. Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer. Eur J Clin Invest 1997;27:645-7.
    • (1997) Eur J Clin Invest , vol.27 , pp. 645-647
    • Virgolini, I.1    Pangeri, T.2    Bischof, C.3    Smith-Jones, P.4    PeckRadosavljevic, M.5
  • 13
    • 5444228828 scopus 로고    scopus 로고
    • From the magic bullet to an effective therapy: The peptide experience
    • DOI 10.1007/s00259-004-1661-3
    • Mansi L. From the magic bullet to an effective therapy: the peptide experience. Eur J Nucl Med Mol Imaging 2004;31:1393-8. (Pubitemid 39361935)
    • (2004) European Journal of Nuclear Medicine and Molecular Imaging , vol.31 , Issue.10 , pp. 1393-1398
    • Mansi, L.1
  • 17
    • 0036226273 scopus 로고    scopus 로고
    • Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
    • de Jong M, Valkema R, Jamar F. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings. Semin Nucl Med 2002;32:133-40.
    • (2002) Semin Nucl Med , vol.32 , pp. 133-140
    • De Jong, M.1    Valkema, R.2    Jamar, F.3
  • 18
    • 14844366257 scopus 로고    scopus 로고
    • A pragmatic perspective on molecular targeted radionuclide therapy
    • Larson SM, Krenning EP. A pragmatic perspective on molecular targeted radionuclide therapy. J Nucl Med 2005;46(Suppl 1):1S-3S.
    • (2005) J Nucl Med , vol.46 , Issue.SUPPL. 1
    • Larson, S.M.1    Krenning, E.P.2
  • 19
    • 59749083610 scopus 로고    scopus 로고
    • Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro
    • Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab 2009;94:654-61.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 654-661
    • Lesche, S.1    Lehmann, D.2    Nagel, F.3    Schmid, H.A.4    Schulz, S.5
  • 21
    • 0037907532 scopus 로고    scopus 로고
    • Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting
    • Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumors: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003;30:781-93. (Pubitemid 36612963)
    • (2003) European Journal of Nuclear Medicine and Molecular Imaging , vol.30 , Issue.5 , pp. 781-793
    • Reubi, J.C.1    Waser, B.2
  • 25
    • 77956639140 scopus 로고    scopus 로고
    • Somatostatin analogues: Treatment of pituitary and neuroendocrine tumors
    • Colao A, Faggiano A, Pivonello R. Somatostatin analogues: treatment of pituitary and neuroendocrine tumors. Prog Brain Res 2010;182:281-94.
    • (2010) Prog Brain Res , vol.182 , pp. 281-294
    • Colao, A.1    Faggiano, A.2    Pivonello, R.3
  • 26
    • 0029929673 scopus 로고    scopus 로고
    • Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: In vitro identification
    • Reubi JC, Waser B, Laissue JA, Gebbers J-O. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 1996;56:1922-31. (Pubitemid 26118233)
    • (1996) Cancer Research , vol.56 , Issue.8 , pp. 1922-1931
    • Reubi, J.C.1    Waser, B.2    Laissue, J.A.3    Gebbers, J.-O.4
  • 27
    • 33744992729 scopus 로고    scopus 로고
    • Potential indications for somatostatin analogues: Immune system and limphoproliferative disorders
    • Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola et al. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. J Endocrinol Invest 2005;28(11 Suppl International):111-7.
    • (2005) J Endocrinol Invest , vol.28 , Issue.11 SUPPL. INTERNATIONAL , pp. 111-117
    • Ferone, D.1    Resmini, E.2    Boschetti, M.3    Arvigo, M.4    Albanese, V.5    Ceresola6
  • 30
    • 77956186159 scopus 로고    scopus 로고
    • Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201T1-chloride
    • Rambaldi PF, Cuccurullo V, Cascini GL, Mansi L. Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201T1-chloride. Eur J Nucl Med Mol Imaging 2010;37:1616.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 1616
    • Rambaldi, P.F.1    Cuccurullo, V.2    Cascini, G.L.3    Mansi, L.4
  • 31
    • 77952510480 scopus 로고    scopus 로고
    • The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology
    • Cascini GL, Cuccurullo V, Mansi L. The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology. Q J Nucl Med Mol Imaging 2010;54:24-36.
    • (2010) Q J Nucl Med Mol Imaging , vol.54 , pp. 24-36
    • Cascini, G.L.1    Cuccurullo, V.2    Mansi, L.3
  • 33
    • 0031789246 scopus 로고    scopus 로고
    • Intraoperative detection of lung cancer by octreotide labeled to Indium- 111
    • DOI 10.1002/(SICI)1098-2388(199812)15:4<220::AID-SSU6>3.0.CO;2-T
    • Pastore V, Di Lieto E, Mansi L, Rambaldi PF, Santini M, Mancusi R. Intraoperative detection of lung cancer by octreotide labeled to Indium-111. Sem Surg Onc 1998;15:220-2. (Pubitemid 28511997)
    • (1998) Seminars in Surgical Oncology , vol.15 , Issue.4 , pp. 220-222
    • Pastore, V.1    Di, L.E.2    Mansi, L.3    Rambaldi, P.F.4    Santini, M.5    Mancusi, R.6
  • 35
    • 0031418445 scopus 로고    scopus 로고
    • Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors
    • Briganti V, Sestini R, Orlando C, Bernini G, La Cava G, Tamburini A et al. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. Clin Cancer Res 1997;3(12 Pt 1):2385-91. (Pubitemid 28133159)
    • (1997) Clinical Cancer Research , vol.3 , Issue.12 I , pp. 2385-2391
    • Briganti, V.1    Sestini, R.2    Orlando, C.3    Bernini, G.4    La, C.G.5    Tamburini, A.6    Raggi, C.C.7    Serio, M.8    Maggi, M.9
  • 36
    • 0031452035 scopus 로고    scopus 로고
    • 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid
    • DOI 10.1530/eje.0.1370688
    • Mansi L, Rambaldi PF, Panza N, Esposito D, Esposito V, Pastore V. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. Eur J Endocrinol 1997;137:688-90. (Pubitemid 28005266)
    • (1997) European Journal of Endocrinology , vol.137 , Issue.6 , pp. 688-690
    • Mansi, L.1    Rambaldi, P.F.2    Panza, N.3    Esposito, D.4    Esposito, V.5    Pastore, V.6
  • 39
    • 0033623561 scopus 로고    scopus 로고
    • 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis
    • Weinmann P, Crestani B, Tazi A, Genereau T, Mal H, Aubier M et al. 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. J Nucl Med 2000;41:1808-12.
    • (2000) J Nucl Med , vol.41 , pp. 1808-1812
    • Weinmann, P.1    Crestani, B.2    Tazi, A.3    Genereau, T.4    Mal, H.5    Aubier, M.6
  • 42
    • 77349104615 scopus 로고    scopus 로고
    • Graves' ophthalmopathy
    • Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010;362:726-38.
    • (2010) N Engl J Med , vol.362 , pp. 726-738
    • Bahn, R.S.1
  • 43
    • 77955375528 scopus 로고    scopus 로고
    • Pathogenesis of Graves' orbitopathy: A 2010 update
    • Smith TJ. Pathogenesis of Graves' orbitopathy: a 2010 update. J Endocrinol Invest 2010;33:414-21.
    • (2010) J Endocrinol Invest , vol.33 , pp. 414-421
    • Smith, T.J.1
  • 44
    • 0033679581 scopus 로고    scopus 로고
    • Somatostatin-receptor scintigraphy in Graves' disease: Reproducibility and variance of orbital activity
    • Förster GJ, Krummenauer F, Nickel O, Kahaly GJ. Somatostatin- receptor scintigraphy in Graves' disease: reproducibility and variance of orbital activity. Cancer Biother Radiopharm 2000;15:517-25.
    • (2000) Cancer Biother Radiopharm , vol.15 , pp. 517-525
    • Förster, G.J.1    Krummenauer, F.2    Nickel, O.3    Kahaly, G.J.4
  • 45
    • 0028955466 scopus 로고
    • Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy
    • Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 1995;30:550-4.
    • (1995) J Nucl Med , vol.30 , pp. 550-554
    • Kahaly, G.1    Diaz, M.2    Hahn, K.3    Beyer, J.4    Bockisch, A.5
  • 46
    • 0033855356 scopus 로고    scopus 로고
    • Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from graves' ophthalmopathy
    • Pasquali D, Vassallo P, Esposito D, Bonavolontà G, Bellastella A, Sinisi AA. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol 2000;25:63-71. (Pubitemid 30617075)
    • (2000) Journal of Molecular Endocrinology , vol.25 , Issue.1 , pp. 63-71
    • Pasquali, D.1    Vassallo, P.2    Esposito, D.3    Bonavolonta, G.4    Bellastella, A.5    Sinisi, A.A.6
  • 47
    • 0028670368 scopus 로고
    • [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: A parameter for disease activity?
    • Postema PT, Krenning EP, Wijngaarde R, Kooy PP, Oei HY, van den Bosch WA et al. [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? J Clin Endocrinol Metab 1994;79:1845-51.
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 1845-1851
    • Postema, P.T.1    Krenning, E.P.2    Wijngaarde, R.3    Kooy, P.P.4    Oei, H.Y.5    Van Den Bosch, W.A.6
  • 50
  • 53
    • 0030934783 scopus 로고    scopus 로고
    • 111In-octreotide
    • Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid 1997;7:21-9. (Pubitemid 27132891)
    • (1997) Thyroid , vol.7 , Issue.1 , pp. 21-29
    • Moncayo, R.1    Baldissera, I.2    Decristoforo, C.3    Kendler, D.4    Donnemiller, E.5
  • 55
    • 0029012202 scopus 로고
    • Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease
    • Krassas GE, Dumas A, Pontikides N, Kaltsas T. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 1995;42:571-80.
    • (1995) Clin Endocrinol , vol.42 , pp. 571-580
    • Krassas, G.E.1    Dumas, A.2    Pontikides, N.3    Kaltsas, T.4
  • 56
    • 0032919656 scopus 로고    scopus 로고
    • Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy
    • DOI 10.1007/s002590050419
    • Nocaudie M, Bailliez A, Itti E, Bauters C, Wemeau JL, Marchandise X. Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. Eur J Nucl Med 1999;26:511-7. (Pubitemid 29209790)
    • (1999) European Journal of Nuclear Medicine , vol.26 , Issue.5 , pp. 511-517
    • Nocaudie, M.1    Bailliez, A.2    Itti, E.3    Bauters, C.4    Wemeau, J.-L.5    Marchandise, X.6
  • 57
    • 33748601201 scopus 로고    scopus 로고
    • Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor
    • DOI 10.1097/01.ten.0000188475.05398.09, PII 0001961620051100000016
    • Teves D.A. Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor. Endocrinologist 2005;15:401-4. (Pubitemid 44378705)
    • (2005) Endocrinologist , vol.15 , Issue.6 , pp. 401-404
    • Teves, D.A.1
  • 59
    • 23844508434 scopus 로고    scopus 로고
    • Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health
    • DOI 10.1210/jc.2004-2527
    • Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-62. (Pubitemid 41159396)
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , Issue.8 , pp. 4955-4962
    • Ilias, I.1    Torpy, D.J.2    Pacak, K.3    Mullen, N.4    Wesley, R.A.5    Nieman, L.K.6
  • 60
    • 29244462313 scopus 로고    scopus 로고
    • Evaluation and treatment of Cushing's syndrome
    • DOI 10.1016/j.amjmed.2005.01.059, PII S0002934305001609
    • Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005;118:1340-6. (Pubitemid 41832323)
    • (2005) American Journal of Medicine , vol.118 , Issue.12 , pp. 1340-1346
    • Nieman, L.K.1    Ilias, I.2
  • 62
    • 28244446189 scopus 로고    scopus 로고
    • Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors
    • Yellin A, Zwas ST, Rozenman J, Simansky DA, Goshen E. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors. Isr Med Assoc J 2005;7:712-6.
    • (2005) Isr Med Assoc J , vol.7 , pp. 712-716
    • Yellin, A.1    Zwas, S.T.2    Rozenman, J.3    Simansky, D.A.4    Goshen, E.5
  • 63
    • 77749270829 scopus 로고    scopus 로고
    • Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors
    • Zemskova MS, Gundabolu B, Sinaii N, Chen CC, Carrasquillo JA, Whatley M et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 2010;95:1207-19.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 1207-1219
    • Zemskova, M.S.1    Gundabolu, B.2    Sinaii, N.3    Chen, C.C.4    Carrasquillo, J.A.5    Whatley, M.6
  • 64
    • 77956383370 scopus 로고    scopus 로고
    • Paraneoplastic syndromes: An approach to diagnosis and treatment
    • Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-54.
    • (2010) Mayo Clin Proc , vol.85 , pp. 838-854
    • Pelosof, L.C.1    Gerber, D.E.2
  • 65
    • 0032798419 scopus 로고    scopus 로고
    • Non-islet cell tumour hypoglycaemia
    • DOI 10.1046/j.1365-2265.1999.00789.x
    • Teale JD. Non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) 1999;51:147. (Pubitemid 29378895)
    • (1999) Clinical Endocrinology , vol.51 , Issue.2 , pp. 147
    • Teale, J.D.1
  • 66
    • 19744366733 scopus 로고    scopus 로고
    • Octreotide in insulinoma patients: Efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
    • DOI 10.1530/eje.1.01901
    • Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B et al. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 2005;152:757-67. (Pubitemid 40744545)
    • (2005) European Journal of Endocrinology , vol.152 , Issue.5 , pp. 757-767
    • Vezzosi, D.1    Bennet, A.2    Rochaix, P.3    Courbon, F.4    Selves, J.5    Pradere, B.6    Buscail, L.7    Susini, C.8    Caron, P.9
  • 68
    • 0029786926 scopus 로고    scopus 로고
    • Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
    • Reubi JC, Schaer JC, Laissue JA, Waser B. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996;45(8 Suppl 1):39-41.
    • (1996) Metabolism , vol.45 , Issue.8 SUPPL. 1 , pp. 39-41
    • Reubi, J.C.1    Schaer, J.C.2    Laissue, J.A.3    Waser, B.4
  • 70
    • 0037198438 scopus 로고    scopus 로고
    • Octreotide for tumor-induced osteomalacia
    • Paglia F, Dionisi S, Minisola S. Octreotide for tumor-induced osteomalacia. N Engl J Med 2002;346:1748-9.
    • (2002) N Engl J Med , vol.346 , pp. 1748-1749
    • Paglia, F.1    Dionisi, S.2    Minisola, S.3
  • 71


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.